List of SBIR/STTR awards granted to Bolder Biotechnology, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. in July, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI142909-01A1 | Phase I | 300,000 | July 12, 2019 | |||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. in July, 2021 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI157684-01A1 | Phase I | 300,000 | July 2, 2021 | |||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. in August, 2021 for $249,876.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | W81XWH21P0089 | Phase I | 249,876 | August 23, 2021 | |||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. in March, 2013 for $3,196,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI084288-03A1 | Phase II | 3,196,000 | March 8, 2013 | |||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. for $819,961.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA086577-02A1 | Phase II | 819,961 | ||||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. for $1,617,340.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS040205-04 | Phase II | 1,617,340 | ||||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. for $338,923.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AR051609-02A1 | Phase II | 338,923 | ||||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. for $1,240,490.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK068949-03A1 | Phase II | 1,240,490 | ||||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. for $863,245.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA084851-02 | Phase II | 863,245 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA099217-01A1 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. for $599,885.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI084288-01 | Phase I | 599,885 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. for $599,901.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI084301-01 | Phase I | 599,901 | ||||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. for $363,565.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI060043-02A1 | Phase II | 363,565 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR051609-01 | Phase I | 100,000 | ||||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. for $749,898.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44NS040205-02A1 | Phase II | 749,898 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. for $303,204.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI058815-01A1 | Phase I | 303,204 | ||||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. for $775,847.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA099217-02A1 | Phase II | 775,847 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. for $111,802.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA088514-01A1 | Phase I | 111,802 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. for $500,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK068949-01 | Phase I | 500,000 | ||||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. for $798,378.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA086543-02 | Phase II | 798,378 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. from the U.S. Department of Health & Human Services. | SBIR | 2R44CA086543-02 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI088928-01 | Phase I | 600,000 | ||||||||
A SBIR Phase II contract was awarded to Bolder Biotechnology, Inc. for $1,976,500.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI058815-02A1 | Phase II | 1,976,500 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA090003-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Bolder Biotechnology, Inc. for $121,844.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM072121-01A1 | Phase I | 121,844 |
